AC IMMUNE SA SF-02 (IMR) — Working Capital to Net Assets Ratio

AC IMMUNE SA SF-02 (IMR) has a Working Capital to Net Assets ratio of -38.7% as of March 2026. Working capital of €-12.20 Million (current assets of €80.05 Million minus current liabilities of €92.25 Million) is measured against net assets of €31.53 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See IMR equity financing ratio to measure how much of total assets are equity-financed.